A NOVEL THERAPEUTIC TARGET FOR MITOCHONDRIAL DYSFUNCTION

A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction plays a wide range of chronic diseases. This deficiency in mitochondrial function can lead to cellular damage, ultimately resulting in multiple pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating issue. EPT Fumarate acts by activating the activity of m

read more